InspireMD (NSPR) Receivables (2010 - 2025)

InspireMD has reported Receivables for 16 years, with the latest figure at $2.6 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables rose 13.93% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 13.93% YoY), and the FY2025 full-year result was $2.6 million, up 13.93% from the prior year.
• Receivables for Q4 2025 stood at $2.6 million, up from $2.4 million in the prior quarter.
• The five-year high for Receivables was $2.6 million in Q4 2025, with the low at $825000.0 in Q1 2021.
• Historically, Receivables has averaged $1.7 million across 5 years, with a median of $1.7 million in 2023.
• The largest YoY upside for Receivables was 123.31% in 2021 against a maximum downside of 19.9% in 2021.
• InspireMD's Receivables stood at $1.4 million in 2021, then declined by 10.22% to $1.2 million in 2022, then soared by 96.63% to $2.5 million in 2023, then fell by 8.08% to $2.3 million in 2024, then advanced by 13.93% to $2.6 million in 2025.
• The last three Receivables figures came in at $2.6 million (Q4 2025), $2.4 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.